4-Month Triple to $30B ARR: Anthropic Revenue Tops OpenAI

Anthropic revenue hits $30B ARR after tripling in four months, surpassing OpenAI's $24B as over 1,000 enterprises pay $1M+ annually and eight of the Fortune 10 adopt Claude.

$30 billion. Four months ago, that number belonged to OpenAI alone. On April 7, 2026, Anthropic revenue on an annualized run-rate basis (ARR, a standard SaaS gauge that multiplies monthly revenue by twelve) crossed $30B — and the company became the first AI startup to pass the chief rival that dominated the sector for three straight years. Read more »

Novo Nordisk × OpenAI: AI Drug Discovery Arms Race Begins

Drug discovery competition intensifies as Novo Nordisk teams with OpenAI while Eli Lilly deploys a $3.75B AI war chest including a $2.75B Insilico Medicine deal.

Drug discovery just entered a new era. On April 14, 2026, Danish pharmaceutical giant Novo Nordisk — the maker of Ozempic and Wegovy — announced a sweeping partnership with OpenAI to embed artificial intelligence agents across its entire operational chain. From genomic data analysis to supply chain optimization, every stage of how a drug is found, made, and delivered is now on the table. Read more »